BACKGROUND Most reviews of IVF ovarian stimulation protocols have insufficiently
accounted for various patient populations, such as ovulatory women, women with polycystic …

Background Gonadotrophin‐releasing hormone (GnRH) antagonists can be used to prevent
a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without …

Arzneiverordnungs-report 2017 Arznei verordnungsReport 2019 Ulrich Schwabe· Dieter Paffrath
Wolf-Dieter Ludwig· Jürgen Klauber Hrsg. Page 2 Arzneiverordnungs-Report 2019 Page 3 Ulrich …

To allow selection of embryos for transfer after in vitro fertilization, ovarian stimulation is
usually carried out with exogenous gonadotropins. To compensate for changes induced by …

Objective: To assess the effect of ovarian stimulation with recombinant FSH, GnRH
antagonists, and hCG on endometrial maturation on the day of oocyte pick-up. Design …

OBJECTIVE: To determine the incidence of ovarian hyperstimulation syndrome (OHSS) in a
large series of GnRH antagonist–stimulated cycles and to assess the predictive value of E2 …

Objective To identify, appraise and summarize the current evidence regarding the
pathophysiology, staging, prediction and prevention of ovarian hyperstimulation syndrome …

The first edition of the Textbook of Assisted Reproductive Techniques was published in
2001. As the textbook now enters its sixth edition, some 45 years since the birth of Louise …

Pulsatile gonadotropin-releasing hormone (GnRH) stimulates the pituitary secretion of both
luteinising hormone (LH) and follicle-stimulating hormone (FSH) and thus controls the …

This paper is based on a Cochrane review published in The Cochrane Library, issue 1,
2002 (see www. CochraneLibrary. net for information) with permission from The Cochrane …